Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alembic Pharmaceuticals Ltd.

www.alembic-india.com

Latest From Alembic Pharmaceuticals Ltd.

People Round-Up: Bhadauria Named As Amneal CSO

Amneal gets a new CSO, Acino restructures its board under a new chair, the AAM adds an assistant general counsel and the British Biosimilars Association names a vice-chair, as well as other people movements from around the generics, biosimilars and value-added medicines industries.

Appointments Strategy

The Quality Lowdown: FDA's Enhanced Drug Recall Authority

Opioid crisis gives US FDA something heparin crisis couldn’t: more drug recall authority in some cases. Meanwhile, Hanlim warning letter and Mercury Labs and Recipharm EU GMP non-compliance statements prove illuminating.

Recalls Manufacturing

Swift And Nimble – Alembic Laps Up US Valsartan Windfall In Q2

Alembic moved fast and seized supply opportunities for valsartan, the hypertension drug that has seen shortages in the US, though management maintains that fundamental changes to the US market are there to stay given the backdrop of buying power of distributors.
Commercial Strategy

India Pharma Q1 Preview: Home Gains But Subdued US Growth

Leading Indian firms are expected to report revenue growth, propped by a strained domestic business in the first quarter of the last fiscal year. But it is management commentary around pricing developments in the US, a key revenue contributor for most frontline firms, and plans around specialty product introductions that are expected to be keenly tracked by investors.

Companies India
See All

Company Information

  • Industry
  • Distributors
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Pulmonary
      • Transdermal
    • Generic Drugs
    • Nutraceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • India
  • Parent & Subsidiaries
  • Alembic Pharmaceuticals Ltd.
  • Senior Management
  • Chirayu R Amin, Chmn. & Managing Dir.
    Pranav Amin, Pres., International Bus.
  • Contact Info
  • Alembic Pharmaceuticals Ltd.
    Phone: (91) 265 228 0550
    Alembic Rd.
    Vadodara
    Gujarat, 390 003
    India
Advertisement
Advertisement
UsernamePublicRestriction

Register